Related Experiment Video
Updated: May 27, 2025

Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
Exploring the association of natriuretic peptides with QTc interval in hemodialysis patients
Yoshihiro Matsumoto1, Yasuo Mori2, Shinji Kageyama3
1Nephrology and Dialysis, Shizuoka City Shizuoka Hospital, Shizuoka, Japan.
Insights
In hemodialysis patients, N-terminal proBNP (NT-proBNP) strongly predicts prolonged QTc intervals, more so than other natriuretic peptides. Monitoring NT-proBNP, potassium, and calcium may help reduce cardiovascular events.
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Background:
- Cardiovascular disease, especially sudden cardiac death, is a leading cause of mortality in hemodialysis patients.
- Prolonged QT interval and elevated natriuretic peptides are known predictors of sudden cardiac death.
- The relationship between natriuretic peptides and QT interval in hemodialysis patients requires further investigation.
Purpose of the Study:
- To explore the association between the QTc interval and various natriuretic peptides (ANP, BNP, NT-proBNP) in hemodialysis patients.
- To identify predictors of a prolonged QTc interval in this patient population.
Main Methods:
- A cross-sectional study of 207 hemodialysis patients with specific ECG criteria (sinus rhythm, no extrasystoles).
- ECG and blood samples for ANP, BNP, and NT-proBNP were collected before dialysis.
- The heart rate-corrected QT (QTc) interval was calculated using Bazett's formula.
Main Results:
- All measured natriuretic peptides (ANP, BNP, NT-proBNP) were significantly associated with the QTc interval in univariate analyses.
- Multiple regression analysis indicated that NT-proBNP was the strongest predictor of the QTc interval.
- Independent predictors of prolonged QTc included lower corrected calcium (cCa), lower potassium (K), and higher log NT-proBNP levels.
Conclusions:
- NT-proBNP demonstrates a stronger association with the QTc interval compared to BNP or ANP in hemodialysis patients.
- Clinical management incorporating QTc interval and NT-proBNP levels may help reduce cardiovascular events.
- Attention to low potassium and corrected calcium levels is advisable for managing the QTc interval in hemodialysis patients.
Background:
In patients undergoing hemodialysis (HD), cardiovascular (CV) disease, particularly sudden cardiac death (SCD), is a major cause of mortality. Independent predictors of SCD include a prolonged QT interval on electrocardiography (ECG) and elevated levels of natriuretic peptides (NPs). This study explores the association between the QTc interval and NPs in HD patients.
Methods:
This cross-sectional study involved 207 HD patients, having a heart rate of 57 to 103 bpm, displaying sinus rhythm and no extrasystoles in ECG reports. Before the 2nd HD of the week, we conducted ECG and blood tests for atrial NP (ANP), brain NP (BNP), and N-terminal proBNP (NT-proBNP). The heart rate-corrected QT (QTc) was calculated using Bazett formula. Our analysis focused on the association between QTc and each NP, along with evaluating clinically relevant variables related to the QTc interval.
Results:
Univariate analyses indicated robust correlations among the NPs, with each NP significantly associated with the QTc interval. Multiple regression analyses of the three NPs revealed that NT-proBNP demonstrated the strongest predictive ability for the QTc interval. Independent predictors of prolonged QTc included lower corrected calcium (cCa) levels (p = 0.001), lower potassium (K) levels (p < 0.001), and higher log NT-proBNP (p = 0.004).
Conclusion:
In HD patients, NT-proBNP shows a stronger link with the QTc interval than BNP or ANP. Integrating clinical management considering both QTc and log NT-proBNP levels might help reduce CV events. Additionally, vigilance regarding low K or cCa levels is recommended from the perspective of the QTc interval.
Related Concept Videos
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Potassium-Sparing Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Thiazide-Class Diuretics
Renal Drug Excretion: Tubular Secretion
Antihypertensive Drugs: Action of Diuretics

